Clinical trial
Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
NCT00098553 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2005
- Completion date
- February 28, 2010
- Enrollment
- 53 (actual)
- Sites
- 94
Conditions
As the registry lists them; a condition with its own page is linked.
melanoma (skin)